Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Large-vessel vasculitis diagnosed between 50 and 60 years: Case-control study based on 183 cases and 183 controls aged over 60 years.

Delaval, Laure; Daumas, Aurélie; Samson, Maxime; Ebbo, Mikael; De Boysson, Hubert; Liozon, Eric; Dupuy, Henry; Puyade, Mathieu; Blockmans, Daniel; Benhamou, Ygal; Sacré, Karim; Berezne, Alice; Devilliers, Hervé; Pugnet, Grégory; Maurier, François; Zénone, Thierry; de Moreuil, Claire; Lifermann, François; Arnaud, Laurent; Espitia, Olivier; Deroux, Alban; Grobost, Vincent; Lazaro, Estibaliz; Agard, Christian; Balageas, Alexandre; Bouiller, Kevin; Durel, Cécile-Audrey; Humbert, Sébastien; Rieu, Virginie; Roriz, Mélanie; Souchaud-Debouverie, Odile; Vinzio, Stéphane; Nguyen, Yann; Régent, Alexis; Guillevin, Loïc; Terrier, Benjamin.
Autoimmun Rev; 18(7): 714-720, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31059846

BACKGROUND:

Age at onset of large-vessel vasculitis (LVV) is commonly used to distinguish giant cell arteritis (GCA) and Takayasu arteritis (TA). However, LVV between age 50 and 60 years may be difficult to classify.

METHODS:

We conducted a retrospective study including LVV aged between 50 and 60 years at onset (LVV50-60, cases) and compared them to LVV aged over 60 years (LVV>60, controls). LVV was defined histologically and/or morphologically. Controls fulfilled ACR 1990 criteria for GCA or presented isolated aortitis.

RESULTS:

We included 183 LVV50-60 and 183 gender-matched LVV>60. LVV50-60 had more frequent peripheral limb manifestations (23 vs. 5%), and less frequent cephalic (73 vs. 90%) and ocular signs (17 vs. 27%) than LVV>60. Compared to LVV>60, CT angiography and PET/CT scan were more frequently abnormal in LVV50-60 (74 vs. 38%, and 90 vs. 72%, respectively), with aorta being more frequently involved (78 vs. 47%). By multivariate analysis, absence of cephalic symptoms, presence of peripheral limb ischemia and aorta involvement, and increased CRP level were significantly associated with LVV50-60 presentation compared to LVV>60. At last follow-up, compared to LVV>60, LVV50-60 received significantly more lines of treatment (2 vs. 1), more frequent biologics (12 vs. 3%), had more surgery (10 vs. 0%), and had higher prednisone dose (8.8 vs. 6.5 mg/d) at last follow-up, CONCLUSION: LVV onset between 50 and 60 years identifies a subset of patients with more frequent aorta and peripheral vascular involvement and more refractory disease compared to patients with LVV onset after 60.
Selo DaSilva